SCHEMBL23071852

SCHEMBL23071852

CC(C(=O)ON1C(=O)CCC1=O)S(=O)(=O)O

nearest known ligand 0.34

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 3/20 0.34
PARL Q9H300 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28635874 0.80 MGLL (0.32) MGLL
SCHEMBL17430432 0.79 MGLL (0.36) MGLL
SCHEMBL258692 0.79 MGLL (0.36) MGLL
SCHEMBL17344122 0.78 RECQL (0.33) MGLLPARL
SCHEMBL31473474 0.78 CA14 (0.38) MGLLPARL
SCHEMBL13551294 0.77 MGLL (0.35) MGLL
SCHEMBL18908274 0.77 MGLL (0.35) MGLL
SCHEMBL12889165 0.76 MGLL (0.33) MGLL
SCHEMBL16153543 0.76 RECQL (0.34) MGLL
SCHEMBL1906467 0.76 MGLL (0.34) MGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10941139-B2 Cryptophycin compounds and conjugates, their preparation and their therapeutic use SANOFI (FR) 2021-03-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10941139-B2 Cryptophycin compounds and conjugates, their preparation and their therapeutic use XPOT, COIL, HCCS MGLL 4776/4885PARL 4449/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.